Few biotech companies have made more noise than Viking Therapeutics (VKTX 3.61%) this year, and that's saying something. The drugmaker had been a relatively small and unknown player in the industry.

In May, Viking announced encouraging results from a phase 2b study of VK2809 in treating non-alcoholic steatohepatitis (NASH). Both weight loss and NASH represent huge potential markets for Viking.

The arrow dates back to around the 6th century AD – which pre-dates the Viking Age by a couple of hundred years. Researchers also found a second arrow in the same location that's not as old ...

COPENHAGEN, Denmark (AP) — An archaeology student unearthed seven “spectacular” Viking-era curled silver arm rings earlier this year north of Denmark’s second-largest city, a Danish museum ...

COPENHAGEN, Denmark (AP) — A strong wave was likely responsible for the capsizing of a Viking ship replica earlier this week off Norway’s coast that killed a U.S. citizen, police said Thursday ...

MINNEAPOLIS — Having destroyed every poor local team that this wide world has to offer, The Viking Raiders have lately taken to sourcing their competition to open challenges. The strategy served ...